Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report

By Hoshi Senji   Ohyama Chikara   Ono Kunio   Takeda Atsushi   Yamashita Shinichi   Yamato Takashi   Itoh Akihiro   Satoh Makoto   Saito Seiichi   Okada Yasuhiro   Sohma Fumihiko   Arai Yoichi  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 125-129

Springer Publishing Company

Access to resources Recommend Favorite

Response to Salvage Treatment in Recurrent Ovarian Cancer Treated Initially with Paclitaxel and Platinum-Based Combination Regimens

By Roland P.Y.   Barnes M.N.   Niwas S.   Robertson M.W.   Alvarez R.   Austin J.M.   Kilgore L.C.   Partridge E.E.  

Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. : 178-182

Elsevier

Access to resources Recommend Favorite

A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1375-1380

Science Publishers

Access to resources Recommend Favorite

Complications Relating to Intraperitoneal Administration of Cisplatin or Carboplatin for Ovarian Carcinoma

By Sakuragi N.   Nakajima A.   Nomura E.   Noro N.   Yamada H.   Yamamoto R.   Fujimoto S.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 420-423

Elsevier

Access to resources Recommend Favorite

Phase II Trial of High-Dose Cisplatin Plus Ifosfamide as First-Line Followed by Carboplatin as Second-Line Treatment in Epithelial Ovarian Carcinoma

By Strauss G.   Lund B.   Hansen M.   Hansen H.H.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 66-70

Elsevier

Access to resources Recommend Favorite